These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14960388)

  • 1. Oligonucleotides make sensible strides.
    Doran G
    Drug Discov Today; 2004 Feb; 9(3):114-6. PubMed ID: 14960388
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of siRNA for therapeutics: efficient synthesis of phosphorothioate RNA utilizing phenylacetyl disulfide (PADS).
    Ravikumar VT; Andrade M; Carty RL; Dan A; Barone S
    Bioorg Med Chem Lett; 2006 May; 16(9):2513-7. PubMed ID: 16481168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modifications of antisense oligonucleotides.
    Urban E; Noe CR
    Farmaco; 2003 Mar; 58(3):243-58. PubMed ID: 12620420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENA oligonucleotides as therapeutics.
    Koizumi M
    Curr Opin Mol Ther; 2006 Apr; 8(2):144-9. PubMed ID: 16610767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-oligonucleotide hybrids in antisense therapy.
    Pierce TL; White AR; Tregear GW; Sexton PM
    Mini Rev Med Chem; 2005 Jan; 5(1):41-55. PubMed ID: 15638791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of antisense RNA.
    Sczakiel G
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):439-44. PubMed ID: 9303196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antisense properties of 2'-O-(2S-methoxypropyl)-RNA-modified gapmer antisense oligonucleotides.
    Yu J; Pandey SK; Khatri H; Prakash TP; Swayze EE; Seth PP
    ChemMedChem; 2014 Sep; 9(9):2040-4. PubMed ID: 24891270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide charge reversal: 2'-O-lysylaminohexyl modified oligonucleotides.
    Winkler J; Noe CR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):939-42. PubMed ID: 18058513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of antisense and siRNAs during preclinical drug development.
    Thompson JD
    Drug Discov Today; 2002 Sep; 7(17):912-7. PubMed ID: 12546934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of modified antisense oligonucleotides and siRNAs as antiviral drugs.
    Wagner A; Bock CT; Fechner H; Kurreck J
    Future Med Chem; 2015; 7(13):1637-42. PubMed ID: 26381598
    [No Abstract]   [Full Text] [Related]  

  • 11. The long march of antisense.
    Jones D
    Nat Rev Drug Discov; 2011 Jun; 10(6):401-2. PubMed ID: 21629279
    [No Abstract]   [Full Text] [Related]  

  • 12. Making dollars and sense of antisense.
    Wiggins P
    Expert Opin Investig Drugs; 2005 Feb; 14(2):111-5. PubMed ID: 15757390
    [No Abstract]   [Full Text] [Related]  

  • 13. Antisense applications for biological control.
    Pan WH; Clawson GA
    J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making sense of antisense and interference.
    Morrow T
    Manag Care; 2003 Nov; 12(11):62-3. PubMed ID: 14666589
    [No Abstract]   [Full Text] [Related]  

  • 15. What's Next for Gastrointestinal Disorders: No Needles?
    Urbanska AM; Karagiannis ED; Au AS; Dai SY; Mozafari M; Prakash S
    J Control Release; 2016 Jan; 221():48-61. PubMed ID: 26646543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: regulatory issues affecting oligonucleotides.
    Crooke ST
    Antisense Res Dev; 1993; 3(3):301-6. PubMed ID: 8286931
    [No Abstract]   [Full Text] [Related]  

  • 17. Sugar boost: when ribose modifications improve oligonucleotide performance.
    Faria M; Ulrich H
    Curr Opin Mol Ther; 2008 Apr; 10(2):168-75. PubMed ID: 18386229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of antisense oligonucleotides for gene functionalization and target validation.
    Bennett CF; Cowsert LM
    Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and properties of double-stranded antisense oligonucleotides connected with a pentaerythritol linker.
    Shibata A; Ueno Y; Matsuda A; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2006; (50):73-4. PubMed ID: 17150823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense technologies have a future fighting neurodegenerative diseases.
    Seidman S; Eckstein F; Grifman M; Soreq H
    Antisense Nucleic Acid Drug Dev; 1999 Aug; 9(4):333-40. PubMed ID: 10463077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.